Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

S Singh; YK Loke; CD Furberg

doi:10.1001/jama.300.12.1439

Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

S Singh, YK Loke, CD Furberg

Research output: Contribution to journal › Article

456 Citations (Scopus)

Original language	English
Pages (from-to)	1439-1450
Number of pages	12
Journal	JAMA: The Journal of the American Medical Association
Volume	300
Issue number	12
DOIs	https://doi.org/10.1001/jama.300.12.1439
Publication status	Published - 2008

Access to Document

10.1001/jama.300.12.1439

Cite this

@article{d71b2dcf5ce745cdb39a5176a7cd1753,

title = "Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis",

author = "S Singh and YK Loke and CD Furberg",

year = "2008",

doi = "10.1001/jama.300.12.1439",

language = "English",

volume = "300",

pages = "1439--1450",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Inhaled anticholonergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

AU - Singh, S

AU - Loke, YK

AU - Furberg, CD

PY - 2008

Y1 - 2008

U2 - 10.1001/jama.300.12.1439

DO - 10.1001/jama.300.12.1439

M3 - Article

VL - 300

SP - 1439

EP - 1450

JO - JAMA

JF - JAMA

SN - 0098-7484

IS - 12

ER -